Contact Molecules for Homologous Proteins | ||||
[Full Bars] |
[SiteTable] |
|
[Back to Search Page] |
[Back to HOMCOS] |
[SupCon3D] |
[help] |
seq_id(%): [0] [30] [40] [50] [60] [70] [80] [90] [95] [100] | [show] [download] [help] |
PID | QueryLength | Homolgous Sequence in PDB | UniProt Query | TITLE |
2752856 | 925 | 214 | O95786(RIGI_HUMAN) | RecName: Full=Antiviral innate immune response receptor RIG-I ;AltName: Full=ATP-dependent RNA helicase DDX58 ; EC=3.6.4.13 ;AltName: Full=DEAD box protein 58;AltName: Full=RIG-I-like receptor 1; Short=RLR-1;AltName: Full=RNA sensor RIG-I ;AltName: Full=Retinoic acid-inducible gene 1 protein; Short=RIG-1;AltName: Full=Retinoic acid-inducible gene I protein; Short=RIG-I; |
QUERYSEQ |
MTTEQRRSLQAFQDYIRKTLDPTYILSYMAPWFREEEVQYIQAEKNNKGPMEAATLFLKFLLELQEEGWFRGFLDALDHAGYSGLYEAIESWDFKKIEKLEEYRLLLKRLQPEFKTRIIPTDIISDLSECLINQECEEILQICSTKGMMA GAEKLVECLLRSDKENWPKTLKLALEKERNKFSELWIVEKGIKDVETEDLEDKMETSDIQIFYQEDPECQNLSENSCPPSEVSDTNLYSPFKPRNYQLELALPAMKGKNTIICAPTGCGKTFVSLLICEHHLKKFPQGQKGKVVFFANQI PVYEQQKSVFSKYFERHGYRVTGISGATAENVPVEQIVENNDIIILTPQILVNNLKKGTIPSLSIFTLMIFDECHNTSKQHPYNMIMFNYLDQKLGGSSGPLPQVIGLTASVGVGDAKNTDEALDYICKLCASLDASVIATVKHNLEELE QVVYKPQKFFRKVESRISDKFKYIIAQLMRDTESLAKRICKDLENLSQIQNREFGTQKYEQWIVTVQKACMVFQMPDKDEESRICKALFLYTSHLRKYNDALIISEHARMKDALDYLKDFFSNVRAAGFDEIEQDLTQRFEEKLQELESV SRDPSNENPKLEDLCFILQEEYHLNPETITILFVKTRALVDALKNWIEGNPKLSFLKPGILTGRGKTNQNTGMTLPAQKCILDAFKASGDHNILIATSVADEGIDIAQCNLVILYEYVGNVIKMIQTRGRGRARGSKCFLLTSNAGVIEK EQINMYKEKMMNDSILRLQTWDEAVFREKILHIQTHEKFIRDSQEKPKPVPDKENKKLLCRKCKALACYTADVRVIEECHYTVLGDAFKECFVSRPHPKPKQFSSFEKRAKIFCARQNCSHDWGIHVKYKTFEIPVIKIESFVVEDIATG VQTLYSKWKDFHFEKIPFDPAEMSK |
925 | region | name | description |
1-925 | CHAIN | /note="Antiviral innate immune response receptor RIG-I" /id="PRO_0000144093" | |
1-87 | DOMAIN | /note="CARD 1" | |
92-172 | DOMAIN | /note="CARD 2" | |
251-430 | DOMAIN | /note="Helicase ATP-binding" | |
610-776 | DOMAIN | /note="Helicase C-terminal" | |
794-925 | DOMAIN | /note="RLR CTR" | |
218-925 | REGION | /note="Interaction with ZC3HAV1" | |
735-925 | REGION | /note="Mediates interaction with RNF135" | |
264-271 | BINDING | /ligand="ATP" /ligand_id="ChEBI:CHEBI:30616" | |
810-810 | BINDING | /ligand="Zn(2+)" /ligand_id="ChEBI:CHEBI:29105" | |
813-813 | BINDING | /ligand="Zn(2+)" /ligand_id="ChEBI:CHEBI:29105" | |
864-864 | BINDING | /ligand="Zn(2+)" /ligand_id="ChEBI:CHEBI:29105" | |
869-869 | BINDING | /ligand="Zn(2+)" /ligand_id="ChEBI:CHEBI:29105" | |
1-925 | DISORDER | predicted by DISOPRED |
MONOMER | |||||||
925 | |||||||
pdb_id | a1 | identity[%]2 | description | ||||
7to0 | A | 100.0 | DDX58_HUMAN Antiviral innate immune response receptor RIG-I | ||||
4a2w | A | 55.7 | D3TI84_ANAPL RETINOIC ACID INDUCIBLE PROTEIN I | ||||
1.a1:asym_id for the homologue. 2.identity[%]2:sequence identity between the query and the homologue. |
HETERO | |||||||
925 | pdb_id | contact mol | homologue | ||||
a3 | description | a4 | identity[%]5 | Ncon6 | description | ||
7jl1[4] | D | RN135_HUMAN E3 ubiquitin-protein ligase RNF135[171 aa] | A | 100.0 /100.0 |
10 /10 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I | |
7jl3[2] | D | RN135_HUMAN E3 ubiquitin-protein ligase RNF135[169 aa] | A | 100.0 /100.0 |
1 /1 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I | |
8g7t[6] | B | RN135_HUMAN E3 ubiquitin-protein ligase RNF135[178 aa] | A | 100.0 /100.0 |
13 /13 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I | |
8g7v[1] | B | RN135_HUMAN E3 ubiquitin-protein ligase RNF135[178 aa] | C | 100.0 /100.0 |
1 /1 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I | |
4nqk[6] | E | UBC_HUMAN Ubiquitin[72 aa] | A | 100.0 /100.0 |
5 /5 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 | |
4nqk[9] | J | UBC_HUMAN Ubiquitin[73 aa] | A | 100.0 /100.0 |
9 /9 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 | |
4nqk[5] | F | UBC_HUMAN Ubiquitin[73 aa] | B | 100.0 /100.0 |
11 /11 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 | |
4p4h[1] | Q | RL40_HUMAN Ubiquitin-60S ribosomal protein L40[73 aa] | H | 100.0 /99.5 |
1 /1 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 | |
4p4h[8] | I | MAVS_HUMAN Mitochondrial antiviral-signaling protein[97 aa] | A | 100.0 /99.5 |
11 /11 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 | |
4p4h[6] | I | MAVS_HUMAN Mitochondrial antiviral-signaling protein[97 aa] | B | 100.0 /99.5 |
6 /6 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 | |
4p4h[3] | I | MAVS_HUMAN Mitochondrial antiviral-signaling protein[97 aa] | C | 100.0 /99.5 |
1 /1 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 | |
4p4h[2] | I | MAVS_HUMAN Mitochondrial antiviral-signaling protein[97 aa] | D | 100.0 /99.5 |
9 /9 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 | |
7jl0[4] | D | TRI65_HUMAN Tripartite motif-containing protein 65[180 aa] | C | 33.3 /40.2 |
9 /11 |
IFIH1_HUMAN Interferon-induced helicase C domain-containing pr.. | |
4i1s[1] | B | V_SV5 Non-structural protein V[52 aa] | A | 44.0 /37.6 |
25 /26 |
A7LCX1_PIG A7LCX1_PIG Melanoma differentiation associated protein-5 | |
7v6c[1] | B | Q9VLW8_DROME R2D2[260 aa] | A | 100.0 /32.5 |
1 /43 |
A1ZAW0_DROME Dicer-2, isoform A | |
5m59[4] | A | G0SFL3_CHATD Putative pre-mRNA splicing factor[266 aa] | B | 28.6 /31.9 |
7 /57 |
G0S0B9_CHATD Pre-mRNA splicing helicase-like protein | |
7w0a[8] | B | M9MRT5_DROME Loquacious, isoform D[16 aa] | A | 33.3 /29.7 |
21 /27 |
A1ZAW0_DROME Dicer-2, isoform A | |
7w0d[1] | C | M9MRT5_DROME Loquacious, isoform D[13 aa] | E | 34.8 /29.7 |
23 /25 |
A1ZAW0_DROME Dicer-2, isoform A | |
8hf0[5] | C | Q9VLW8_DROME LD06392p[126 aa] | A | 19.0 /29.7 |
21 /31 |
A1ZAW0_DROME Dicer-2, isoform A | |
8hf0[3] | C | Q9VLW8_DROME LD06392p[126 aa] | D | 20.0 /29.7 |
5 /11 |
A1ZAW0_DROME Dicer-2, isoform A | |
8hf1[1] | B | M9MRT5_DROME Loquacious, isoform D[16 aa] | A | 31.6 /29.7 |
19 /23 |
A1ZAW0_DROME Dicer-2, isoform A | |
8dfv[2] | C | Q9VJY9_DROME Loquacious, isoform B[253 aa] | A | 0.0 /24.1 |
3 /55 |
DCR1_DROME Endoribonuclease Dcr-1 | |
8dg7[1] | D | Q9VJY9_DROME Loquacious, isoform B[181 aa] | A | 0.0 /23.7 |
3 /46 |
DCR1_DROME Endoribonuclease Dcr-1 | |
8dgi[2] | B | Q9VJY9_DROME Loquacious, isoform B[108 aa] | A | 0.0 /23.7 |
2 /23 |
DCR1_DROME Endoribonuclease Dcr-1 | |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. | |||||||
NUCLEOTIDE | |||||||
925 | pdb_id | contact mol | homologue | ||||
a3 | description | a4 | identity[%]5 | Ncon6 | description | ||
3ncu[2] | C | 5'-R(*(GDP)P*AP*CP*GP*CP*UP*AP*GP*CP*GP*UP*C)-3' | A | 100.0 /100.0 |
13 /13 |
DDX58_HUMAN RIG-I | |
3ncu[2] | D | 5'-R(*(GDP)P*AP*CP*GP*CP*UP*AP*GP*CP*GP*UP*C)-3' | A | 100.0 /100.0 |
4 /4 |
DDX58_HUMAN RIG-I | |
7bai[4] | C | RNA (5'-R(*(GDP)P*AP*CP*GP*CP*UP*AP*GP*CP*GP*UP*C).. | A | 100.0 /100.0 |
11 /11 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I | |
7bai[4] | D | RNA (5'-R(*(GDP)P*AP*CP*GP*CP*UP*AP*GP*CP*GP*UP*C).. | A | 100.0 /100.0 |
3 /3 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I | |
5e3h[1] | B | RNA (5'-R(*CP*GP*AP*CP*GP*CP*UP*AP*GP*CP*GP*U)-3').. | A | 100.0 /100.0 |
18 /18 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 | |
5e3h[1] | C | RNA (5'-R(*CP*GP*AP*CP*GP*CP*UP*AP*GP*CP*GP*U)-3').. | A | 100.0 /100.0 |
27 /27 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 | |
5f98[12] | B | RNA (5'-R(P*GP*AP*AP*UP*AP*UP*AP*AP*UP*AP*GP*UP*GP.. | A | 100.0 /100.0 |
40 /40 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 | |
5f9h[6] | B | RNA (5'-R(P*AP*AP*UP*AP*UP*AP*AP*UP*AP*GP*UP*GP*AP.. | A | 100.0 /100.0 |
37 /37 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 | |
6kyv[6] | A | RNA (5'-R(*GP*GP*UP*AP*GP*AP*CP*GP*CP*UP*UP*CP*GP*.. | B | 100.0 /100.0 |
46 /46 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 | |
7bah[2] | C | RNA (5'-R(*GP*AP*CP*GP*CP*UP*AP*GP*CP*GP*UP*C)-3').. | A | 100.0 /100.0 |
11 /11 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I | |
7bah[2] | D | RNA (5'-R(*GP*AP*CP*GP*CP*UP*AP*GP*CP*GP*UP*C)-3').. | A | 100.0 /100.0 |
3 /3 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I | |
7jl0[1] | A | RNA (5'-R(P*GP*AP*CP*UP*GP*AP*CP*UP*GP*AP*CP*UP*GP.. | C | 60.0 /40.2 |
10 /11 |
IFIH1_HUMAN Interferon-induced helicase C domain-containing pr.. | |
7jl1[1] | B | dsRNA strand 1 | A | 100.0 /100.0 |
17 /17 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I | |
7jl0[1] | B | RNA (5'-R(P*UP*CP*AP*GP*UP*CP*AP*GP*UP*CP*AP*GP*UP.. | C | 71.4 /40.2 |
21 /21 |
IFIH1_HUMAN Interferon-induced helicase C domain-containing pr.. | |
7jl1[1] | C | dsRNA strand 2 | A | 100.0 /100.0 |
27 /27 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I | |
7jl3[3] | G | dsRNA strand1 | A | 100.0 /100.0 |
14 /14 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I | |
7jl3[3] | H | dsRNA strand 2 | A | 100.0 /100.0 |
24 /24 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I | |
7mk1[2] | C | DNA (41-MER) | A | 100.0 /100.0 |
17 /17 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I | |
7tnx[1] | B | p3dsRNAa | A | 100.0 /100.0 |
24 /24 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I | |
7tnx[1] | C | p3dsRNAb | A | 100.0 /100.0 |
21 /21 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I | |
7tny[2] | B | p2dsRNA | A | 100.0 /100.0 |
26 /26 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I | |
7tny[2] | C | p2dsRNA | A | 100.0 /100.0 |
29 /29 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I | |
7to0[1] | B | OHdsRNA | A | 100.0 /100.0 |
27 /27 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I | |
7to0[1] | C | OHdsRNA | A | 100.0 /100.0 |
28 /28 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I | |
7to1[1] | B | p3SLR30 | A | 100.0 /100.0 |
41 /41 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I | |
7to2[1] | B | p3SLR30 | A | 100.0 /100.0 |
57 /57 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I | |
8dvr[1] | B | p3SLR30 | A | 100.0 /100.0 |
33 /33 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I | |
8dvs[1] | B | OHSLR30 | A | 100.0 /100.0 |
48 /48 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I | |
8dvu[1] | B | OHSLR30 | A | 100.0 /100.0 |
55 /55 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I | |
8g7t[2] | E | p3dsRNA24a | A | 100.0 /100.0 |
22 /22 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I | |
8g7t[2] | E | p3dsRNA24a | C | 100.0 /100.0 |
21 /21 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I | |
8g7t[2] | F | p3dsRNA24b | A | 100.0 /100.0 |
24 /24 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I | |
8g7t[2] | F | p3dsRNA24b | C | 100.0 /100.0 |
16 /16 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I | |
8g7v[2] | E | p3dsRNA24a | A | 100.0 /100.0 |
21 /21 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I | |
8g7v[2] | F | p3dsRNA24b | A | 100.0 /100.0 |
19 /19 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I | |
8scz[1] | B | p3SLR30 | A | 100.0 /100.0 |
42 /42 |
RIGI_HUMAN Antiviral innate immune response receptor RIG-I | |
8sd0[1] | B | p3SLR14 | A | 100.0 /100.0 |
39 /39 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I | |
6gpg[1] | A | RNA (5'-R(*CP*GP*AP*CP*GP*CP*UP*AP*GP*CP*GP*UP*CP*.. | C | 100.0 /99.8 |
19 /19 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 | |
6gpg[1] | B | RNA (5'-R(*CP*GP*AP*CP*GP*CP*UP*AP*GP*CP*GP*UP*CP*.. | C | 100.0 /99.8 |
29 /29 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 | |
4ay2[1] | B | 5'-R-PPP(GP*GP*CP*GP*CP*GP*GP*CP*UP*UP*CP*GP*GP*CP.. | A | 100.0 /99.7 |
31 /31 |
DDX58_HUMAN PROBABLE ATP-DEPENDENT RNA HELICASE DDX58 | |
2ykg[4] | B | 5'-R(*GP*CP*GP*CP*GP*CP*GP*CP*GP*CP)-3' | A | 100.0 /99.5 |
16 /16 |
DDX58_HUMAN PROBABLE ATP-DEPENDENT RNA HELICASE DDX58 | |
2ykg[4] | C | 5'-R(*GP*CP*GP*CP*GP*CP*GP*CP*GP*CP)-3' | A | 100.0 /99.5 |
16 /16 |
DDX58_HUMAN PROBABLE ATP-DEPENDENT RNA HELICASE DDX58 | |
3og8[2] | C | RNA (5'-R(*GP*GP*CP*GP*CP*GP*CP*GP*CP*GP*CP*GP*CP*.. | A | 90.9 /99.2 |
11 /11 |
RIGI_HUMAN Antiviral innate immune response receptor RIG-I | |
3og8[2] | D | RNA (5'-R(*GP*GP*CP*GP*CP*GP*CP*GP*CP*GP*CP*GP*CP*.. | A | 100.0 /99.2 |
4 /4 |
RIGI_HUMAN Antiviral innate immune response receptor RIG-I | |
3lrn[2] | C | RNA (5'-R(*(GTP)P*GP*CP*GP*CP*GP*CP*GP*CP*GP*CP*GP.. | A | 93.3 /99.2 |
15 /15 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 | |
3lrn[2] | D | RNA (5'-R(*(GTP)P*GP*CP*GP*CP*GP*CP*GP*CP*GP*CP*GP.. | A | 100.0 /99.2 |
3 /3 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 | |
3lrr[2] | C | RNA (5'-R(*(ATP)P*UP*AP*UP*AP*UP*AP*UP*AP*UP*AP*U).. | A | 93.3 /99.2 |
15 /15 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 | |
3lrr[2] | D | RNA (5'-R(*(ATP)P*UP*AP*UP*AP*UP*AP*UP*AP*UP*AP*U).. | A | 100.0 /99.2 |
4 /4 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 | |
4a36[1] | C | 5'-R(*GP*CP*AP*UP*GP*CP*GP*AP*CP*CP*UP*CP*UP*GP *U.. | A | 28.6 /60.0 |
7 /7 |
D3TI84_ANAPL RETINOIC ACID INDUCIBLE PROTEIN I | |
4a36[1] | D | 5'-R(*UP*CP*AP*AP*AP*CP*AP*GP*AP*GP*GP*UP*CP*GP *C.. | A | 70.8 /60.0 |
24 /24 |
D3TI84_ANAPL RETINOIC ACID INDUCIBLE PROTEIN I | |
4a36[1] | E | 5'-R(*GP*CP*AP*UP*GP*CP*GP*AP*CP*CP*UP*CP*UP*GP *U.. | B | 28.6 /59.7 |
7 /7 |
D3TI84_ANAPL RETINOIC ACID INDUCIBLE PROTEIN I | |
4a36[1] | F | 5'-R(*UP*CP*AP*AP*AP*CP*AP*GP*AP*GP*GP*UP*CP*GP *C.. | B | 72.0 /59.7 |
25 /25 |
D3TI84_ANAPL RETINOIC ACID INDUCIBLE PROTEIN I | |
4a2x[2] | E | 5'-R(*GP*GP*GP*AP*GP*AP*AP*CP*AP*AP*CP*GP*CP*GP)-3.. | A | 88.9 /55.3 |
9 /9 |
D3TI84_ANAPL RETINOIC ACID INDUCIBLE PROTEIN I | |
4a2x[2] | E | 5'-R(*GP*GP*GP*AP*GP*AP*AP*CP*AP*AP*CP*GP*CP*GP)-3.. | B | 100.0 /55.3 |
1 /1 |
D3TI84_ANAPL RETINOIC ACID INDUCIBLE PROTEIN I | |
4a2x[2] | F | 5'-R(*CP*GP*CP*GP*UP*UP*GP*UP*UP*CP*UP*CP*CP*CP)-3.. | A | 0.0 /55.3 |
2 /2 |
D3TI84_ANAPL RETINOIC ACID INDUCIBLE PROTEIN I | |
4a2x[2] | F | 5'-R(*CP*GP*CP*GP*UP*UP*GP*UP*UP*CP*UP*CP*CP*CP)-3.. | B | 88.9 /55.3 |
9 /9 |
D3TI84_ANAPL RETINOIC ACID INDUCIBLE PROTEIN I | |
4gl2[2] | C | RNA (5'-R(*AP*UP*CP*CP*GP*CP*GP*GP*CP*CP*CP*U)-3').. | A | 46.2 /41.4 |
13 /14 |
IFIH1_HUMAN Interferon-induced helicase C domain-containing pr.. | |
4gl2[2] | F | RNA (5'-R(P*AP*GP*GP*GP*CP*CP*GP*CP*GP*GP*AP*U)-3'.. | A | 58.6 /41.4 |
29 /29 |
IFIH1_HUMAN Interferon-induced helicase C domain-containing pr.. | |
7jl2[3] | A | RNA (44-MER) | C | 53.8 /40.2 |
13 /14 |
IFIH1_HUMAN Interferon-induced helicase C domain-containing pr.. | |
7jl2[3] | B | RNA (44-MER) | C | 57.1 /40.2 |
21 /21 |
IFIH1_HUMAN Interferon-induced helicase C domain-containing pr.. | |
6gkh[1] | B | RNA (5'-R(P*GP*UP*CP*AP*AP*GP*CP*CP*GP*AP*GP*GP*AP.. | A | 50.0 /39.0 |
14 /15 |
IFIH1_MOUSE Interferon-induced helicase C domain-containing pr.. | |
7nic[1] | B | RNA (5'-R(P*GP*UP*CP*AP*AP*GP*CP*CP*GP*AP*GP*GP*AP.. | A | 33.3 /38.8 |
18 /19 |
IFIH1_MOUSE Interferon-induced helicase C domain-containing pr.. | |
6gkh[2] | C | RNA (5'-R(P*UP*CP*UP*CP*CP*UP*CP*GP*GP*CP*UP*UP*GP.. | A | 65.4 /39.0 |
26 /26 |
IFIH1_MOUSE Interferon-induced helicase C domain-containing pr.. | |
7niq[1] | B | RNA (5'-R(P*CP*AP*AP*GP*CP*CP*GP*AP*GP*GP*AP*GP*AP.. | A | 50.0 /38.8 |
16 /18 |
IFIH1_MOUSE Interferon-induced helicase C domain-containing pr.. | |
7niq[1] | C | RNA (5'-R(P*AP*UP*CP*UP*CP*CP*UP*CP*GP*GP*CP*UP*UP.. | A | 63.6 /38.8 |
22 /22 |
IFIH1_MOUSE Interferon-induced helicase C domain-containing pr.. | |
6g1s[1] | B | RNA (5'-R(P*UP*CP*CP*AP*UP*GP*CP*GP*CP*AP*UP*GP*AP.. | A | 50.0 /39.6 |
14 /15 |
IFIH1_MOUSE Interferon-induced helicase C domain-containing pr.. | |
6g1x[1] | B | RNA (5'-R(P*UP*CP*CP*AP*UP*GP*CP*GP*CP*AP*UP*GP*AP.. | A | 50.0 /39.5 |
10 /11 |
IFIH1_MOUSE Interferon-induced helicase C domain-containing pr.. | |
6h61[3] | B | RNA (5'-R(P*UP*CP*CP*AP*UP*GP*CP*GP*CP*AP*UP*GP*AP.. | A | 53.3 /39.2 |
15 /15 |
IFIH1_MOUSE Interferon-induced helicase C domain-containing pr.. | |
7bkq[2] | B | RNA (5'-R(P*UP*CP*CP*AP*UP*GP*CP*GP*CP*AP*UP*GP*AP.. | A | 54.5 /38.6 |
11 /12 |
IFIH1_MOUSE Isoform 2 of Interferon-induced helicase C domain-.. | |
7bkq[1] | B | RNA (5'-R(P*UP*CP*CP*AP*UP*GP*CP*GP*CP*AP*UP*GP*AP.. | A | 0.0 /38.6 |
2 /2 |
IFIH1_MOUSE Isoform 2 of Interferon-induced helicase C domain-.. | |
7bkq[1] | B | RNA (5'-R(P*UP*CP*CP*AP*UP*GP*CP*GP*CP*AP*UP*GP*AP.. | A | 0.0 /38.6 |
2 /2 |
IFIH1_MOUSE Isoform 2 of Interferon-induced helicase C domain-.. | |
6g1s[1] | C | RNA (5'-R(P*CP*GP*UP*CP*AP*UP*GP*CP*GP*CP*AP*UP*GP.. | A | 69.2 /39.6 |
26 /26 |
IFIH1_MOUSE Interferon-induced helicase C domain-containing pr.. | |
6g1x[3] | C | RNA (5'-R(P*CP*GP*UP*CP*AP*UP*GP*CP*GP*CP*AP*UP*GP.. | A | 64.0 /39.5 |
25 /25 |
IFIH1_MOUSE Interferon-induced helicase C domain-containing pr.. | |
6h61[3] | C | RNA (5'-R(P*CP*GP*UP*CP*AP*UP*GP*CP*GP*CP*AP*UP*GP.. | A | 70.4 /39.2 |
27 /27 |
IFIH1_MOUSE Interferon-induced helicase C domain-containing pr.. | |
7bkq[1] | C | RNA (5'-R(P*CP*GP*UP*CP*AP*UP*GP*CP*GP*CP*AP*UP*GP.. | A | 100.0 /38.6 |
1 /1 |
IFIH1_MOUSE Isoform 2 of Interferon-induced helicase C domain-.. | |
6g19[1] | B | RNA (5'-R(P*CP*AP*AP*GP*CP*CP*GP*AP*GP*GP*AP*GP*AP.. | A | 47.4 /38.8 |
19 /21 |
IFIH1_MOUSE Interferon-induced helicase C domain-containing pr.. | |
6gjz[2] | B | RNA (5'-R(P*CP*AP*AP*GP*CP*CP*GP*AP*GP*GP*AP*GP*AP.. | A | 47.4 /38.8 |
19 /21 |
IFIH1_MOUSE Interferon-induced helicase C domain-containing pr.. | |
7bkp[1] | C | RNA (5'-R(P*CP*AP*AP*GP*CP*CP*GP*AP*GP*GP*AP*GP*AP.. | A | 44.4 /38.3 |
18 /20 |
IFIH1_MOUSE Interferon-induced helicase C domain-containing pr.. | |
6g19[1] | C | RNA (5'-R(P*CP*UP*CP*UP*CP*CP*UP*CP*GP*GP*CP*UP*UP.. | A | 58.6 /38.8 |
29 /29 |
IFIH1_MOUSE Interferon-induced helicase C domain-containing pr.. | |
6gjz[3] | C | RNA (5'-R(P*CP*UP*CP*UP*CP*CP*UP*CP*GP*GP*CP*UP*UP.. | A | 60.0 /38.8 |
30 /30 |
IFIH1_MOUSE Interferon-induced helicase C domain-containing pr.. | |
5jaj[1] | C | RNA (5'-R(P*GP*GP*UP*AP*CP*GP*UP*AP*CP*C)-3') | A | 70.3 /35.4 |
37 /37 |
G0YYQ5_CHICK LGP2 | |
5jc3[6] | B | RNA (5'-R(P*GP*GP*UP*AP*CP*GP*UP*AP*CP*C)-3') | A | 45.0 /38.1 |
20 /20 |
D9N195_CHICK Melanoma differentiation associated protein-5 | |
5jc3[5] | C | RNA (5'-R(P*GP*GP*UP*AP*CP*GP*UP*AP*CP*C)-3') | A | 56.7 /38.1 |
30 /30 |
D9N195_CHICK Melanoma differentiation associated protein-5 | |
5jc7[1] | C | RNA (5'-R(P*GP*GP*AP*CP*GP*UP*CP*AP*UP*GP*CP*GP*CP.. | A | 45.0 /38.0 |
20 /20 |
D9N195_CHICK Melanoma differentiation associated protein-5 | |
5jc7[1] | C | RNA (5'-R(P*GP*GP*AP*CP*GP*UP*CP*AP*UP*GP*CP*GP*CP.. | B | 60.0 /37.9 |
30 /30 |
D9N195_CHICK Melanoma differentiation associated protein-5 | |
5jc7[1] | D | RNA (5'-R(P*GP*GP*GP*AP*CP*GP*UP*CP*AP*UP*GP*CP*GP.. | A | 58.1 /38.0 |
31 /31 |
D9N195_CHICK Melanoma differentiation associated protein-5 | |
5jc7[1] | D | RNA (5'-R(P*GP*GP*GP*AP*CP*GP*UP*CP*AP*UP*GP*CP*GP.. | B | 47.4 /37.9 |
19 /19 |
D9N195_CHICK Melanoma differentiation associated protein-5 | |
5jcf[1] | C | RNA (5'-R(P*AP*GP*GP*UP*AP*CP*GP*UP*AP*CP*C)-3') | A | 62.1 /37.8 |
29 /29 |
D9N195_CHICK Melanoma differentiation associated protein-5 | |
5jbj[1] | B | RNA (5'-R(P*GP*GP*UP*AP*GP*CP*GP*CP*UP*AP*CP*C)-3'.. | A | 30.8 /35.9 |
26 /26 |
G0YYQ5_CHICK LGP2 | |
5jbj[1] | C | RNA (5'-R(P*GP*GP*UP*AP*GP*CP*GP*CP*UP*AP*CP*C)-3'.. | A | 70.6 /35.9 |
34 /34 |
G0YYQ5_CHICK LGP2 | |
5jaj[1] | B | RNA (5'-R(P*GP*GP*UP*AP*CP*GP*UP*AP*CP*CP*C)-3') | A | 30.8 /35.4 |
26 /26 |
G0YYQ5_CHICK LGP2 | |
5jbg[1] | B | RNA (5'-R(*GPPP*GP*AP*GP*CP*GP*UP*GP*CP*CP*GP*GP*G.. | A | 44.8 /35.1 |
67 /67 |
G0YYQ5_CHICK LGP2 | |
5jb2[1] | B | RNA (5'-R(*GPPP*GP*UP*AP*CP*GP*UP*AP*CP*CP*C)-3') .. | A | 30.8 /34.8 |
26 /26 |
G0YYQ5_CHICK LGP2 | |
5jb2[1] | C | RNA (5'-R(*GPPP*GP*UP*AP*CP*GP*UP*AP*CP*C)-3') | A | 69.4 /34.8 |
36 /36 |
G0YYQ5_CHICK LGP2 | |
8t5s[1] | B | RNA (30-MER) | A | 31.8 /34.0 |
22 /25 |
G5EDI8_CAEEL Dicer-related helicase | |
8t5s[1] | C | RNA (30-MER) | A | 42.4 /34.0 |
33 /34 |
G5EDI8_CAEEL Dicer-related helicase | |
6bu9[1] | B | RNA (5'-R(*GP*GP*AP*GP*GP*UP*AP*GP*UP*AP*GP*GP*UP*.. | A | 0.0 /33.7 |
1 /1 |
A1ZAW0_DROME Dicer-2, isoform A | |
7yym[3] | B | 59-nt precursor of miR-15a | A | 0.0 /33.7 |
1 /15 |
DICER_MOUSE Endoribonuclease Dicer | |
5zal[1] | C | RNA (73-mer) | A | 50.0 /32.8 |
4 /31 |
DICER_HUMAN Endoribonuclease Dicer | |
5zam[1] | C | RNA (73-mer) | A | 100.0 /32.8 |
2 /27 |
DICER_HUMAN Endoribonuclease Dicer | |
7v6c[1] | C | RNA (5'-R(P*UP*GP*AP*GP*G)-3') | A | 25.0 /32.5 |
4 /5 |
A1ZAW0_DROME Dicer-2, isoform A | |
7v6c[1] | D | RNA (5'-R(P*CP*CP*UP*CP*UP*CP*U)-3') | A | 57.1 /32.5 |
7 /8 |
A1ZAW0_DROME Dicer-2, isoform A | |
7eld[1] | B | pri-miRNA 166f | A | 26.5 /32.3 |
34 /74 |
DCL1_ARATH Endoribonuclease Dicer homolog 1 | |
7ele[1] | B | pre-miRNA 166f | A | 25.8 /32.3 |
31 /63 |
DCL1_ARATH Endoribonuclease Dicer homolog 1 | |
3eqt[2] | C | 5'-R(*GP*CP*GP*CP*GP*CP*GP*C)-3' | A | 40.0 /31.2 |
15 /15 |
DHX58_HUMAN ATP-dependent RNA helicase DHX58 | |
3eqt[2] | D | 5'-R(*GP*CP*GP*CP*GP*CP*GP*C)-3' | A | 66.7 /31.2 |
6 /6 |
DHX58_HUMAN ATP-dependent RNA helicase DHX58 | |
5v9x[1] | B | ssDNA | A | 23.1 /31.1 |
13 /52 |
A0A0D6HFY2_MYCSM ATP-dependent DNA helicase | |
7w0a[2] | C | RNA (30-MER) | A | 28.6 /29.7 |
7 /17 |
A1ZAW0_DROME Dicer-2, isoform A | |
7w0a[2] | D | RNA (32-MER) | A | 50.0 /29.7 |
22 /29 |
A1ZAW0_DROME Dicer-2, isoform A | |
7w0c[1] | C | RNA (35-MER) | A | 18.2 /29.7 |
11 /20 |
A1ZAW0_DROME Dicer-2, isoform A | |
7w0c[1] | D | RNA (35-MER) | A | 47.6 /29.7 |
21 /29 |
A1ZAW0_DROME Dicer-2, isoform A | |
7w0d[2] | B | dsRNA | D | 50.0 /29.7 |
20 /37 |
A1ZAW0_DROME Dicer-2, isoform A | |
7w0d[2] | F | dsRNA | D | 25.0 /29.7 |
8 /22 |
A1ZAW0_DROME Dicer-2, isoform A | |
7w0e[1] | A | dsRNA | C | 30.0 /29.7 |
10 /38 |
A1ZAW0_DROME Dicer-2, isoform A | |
7w0e[1] | B | dsRNA | C | 45.0 /29.7 |
20 /61 |
A1ZAW0_DROME Dicer-2, isoform A | |
7w0f[1] | E | siRNA | A | 27.3 /29.7 |
11 /19 |
A1ZAW0_DROME Dicer-2, isoform A | |
7w0f[1] | F | siRNA | A | 47.4 /29.7 |
19 /32 |
A1ZAW0_DROME Dicer-2, isoform A | |
8hf0[2] | F | RNA (52-MER) | A | 30.0 /29.7 |
10 /15 |
A1ZAW0_DROME Dicer-2, isoform A | |
8hf0[2] | G | RNA (52-MER) | A | 47.4 /29.7 |
19 /24 |
A1ZAW0_DROME Dicer-2, isoform A | |
8hf1[3] | E | RNA (5'-R(P*GP*AP*GP*AP*CP*UP*UP*GP*G)-3') | A | 42.9 /29.7 |
7 /13 |
A1ZAW0_DROME Dicer-2, isoform A | |
8hf1[3] | H | RNA (5'-R(P*CP*CP*AP*AP*GP*UP*CP*UP*CP*UP*U)-3') | A | 50.0 /29.7 |
18 /23 |
A1ZAW0_DROME Dicer-2, isoform A | |
8dfv[1] | B | RNA (60-MER) | A | 100.0 /24.1 |
1 /79 |
DCR1_DROME Endoribonuclease Dcr-1 | |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. | |||||||
COMPOUND | |||||||
925 | pdb_id | contact mol | homologue | ||||
a3 | description | a4 | identity[%]5 | Ncon6 | description | ||
5f98[6] | O |
M7G
7N-METHYL-8-HYDROGUANOSINE-5'-DIPHOSPHATE[29 atoms.. |
A | 100.0 /100.0 |
7 /7 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 | |
5f9h[6] | Q |
GTP
GUANOSINE-5'-TRIPHOSPHATE[32 atoms] |
A | 100.0 /100.0 |
10 /10 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 | |
8dvr[1] | D |
GTP
GUANOSINE-5'-TRIPHOSPHATE[32 atoms] |
A | 100.0 /100.0 |
10 /10 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I | |
3tbk[4] | B |
ANP
PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER[31 ato.. |
A | 91.7 /78.8 |
12 /12 |
DDX58_MOUSE RIG-I Helicase Domain | |
5v9x[1] | C |
ANP
PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER[31 ato.. |
A | 100.0 /31.1 |
6 /17 |
A0A0D6HFY2_MYCSM ATP-dependent DNA helicase | |
6gjz[1] | E |
ANP
PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER[31 ato.. |
A | 77.8 /38.8 |
9 /10 |
IFIH1_MOUSE Interferon-induced helicase C domain-containing pr.. | |
6gkm[2] | E |
ATP
ADENOSINE-5'-TRIPHOSPHATE[31 atoms] |
A | 77.8 /38.5 |
9 /10 |
IFIH1_MOUSE Interferon-induced helicase C domain-containing pr.. | |
3zd7[22] | F |
ADP
ADENOSINE-5'-DIPHOSPHATE[27 atoms] |
A | 100.0 /99.4 |
14 /14 |
DDX58_HUMAN PROBABLE ATP-DEPENDENT RNA HELICASE DDX58 | |
6gkh[4] | D |
ADP
ADENOSINE-5'-DIPHOSPHATE[27 atoms] |
A | 81.8 /39.0 |
11 /13 |
IFIH1_MOUSE Interferon-induced helicase C domain-containing pr.. | |
6qv3[1] | B |
ADP
ADENOSINE-5'-DIPHOSPHATE[27 atoms] |
A | 71.4 /31.9 |
7 /13 |
G0S0B9_CHATD Pre-mRNA splicing helicase-like protein | |
6qv3[1] | D |
ADP
ADENOSINE-5'-DIPHOSPHATE[27 atoms] |
A | 100.0 /31.9 |
1 /13 |
G0S0B9_CHATD Pre-mRNA splicing helicase-like protein | |
7jl0[4] | F |
ADP
ADENOSINE-5'-DIPHOSPHATE[27 atoms] |
C | 80.0 /40.2 |
10 /11 |
IFIH1_HUMAN Interferon-induced helicase C domain-containing pr.. | |
7jl1[4] | E |
ADP
ADENOSINE-5'-DIPHOSPHATE[27 atoms] |
A | 100.0 /100.0 |
10 /10 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I | |
7to2[3] | E |
ADP
ADENOSINE-5'-DIPHOSPHATE[27 atoms] |
A | 100.0 /100.0 |
12 /12 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I | |
8t5s[1] | F |
ADP
ADENOSINE-5'-DIPHOSPHATE[27 atoms] |
A | 87.5 /34.0 |
8 /11 |
G5EDI8_CAEEL Dicer-related helicase | |
6qv4[1] | E |
AGS
PHOSPHOTHIOPHOSPHORIC ACID-ADENYLATE ESTER[31 atom.. |
A | 75.0 /31.9 |
8 /17 |
G0S0B9_CHATD Pre-mRNA splicing helicase-like protein | |
6qv4[1] | F |
AGS
PHOSPHOTHIOPHOSPHORIC ACID-ADENYLATE ESTER[31 atom.. |
A | 33.3 /31.9 |
3 /16 |
G0S0B9_CHATD Pre-mRNA splicing helicase-like protein | |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. | |||||||
METAL | |||||||
925 | pdb_id | contact mol | homologue | ||||
a3 | description | a4 | identity[%]5 | Ncon6 | description | ||
4on9[1] | G |
CL
CHLORIDE ION[1 atoms] |
B | 100.0 /100.0 |
2 /2 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 | |
6bzh[1] | G |
CL
CHLORIDE ION[1 atoms] |
A | 66.7 /76.5 |
3 /3 |
DDX58_MOUSE Probable ATP-dependent RNA helicase DDX58 | |
6bzh[1] | H |
CL
CHLORIDE ION[1 atoms] |
A | 100.0 /76.5 |
1 /1 |
DDX58_MOUSE Probable ATP-dependent RNA helicase DDX58 | |
6bzh[1] | L |
CL
CHLORIDE ION[1 atoms] |
D | 0.0 /76.5 |
3 /3 |
DDX58_MOUSE Probable ATP-dependent RNA helicase DDX58 | |
3b6e[1] | B |
NA
SODIUM ION[1 atoms] |
A | 100.0 /51.0 |
5 /5 |
IFIH1_HUMAN Interferon-induced helicase C domain-containing pr.. | |
2qfb[10] | K |
ZN
ZINC ION[1 atoms] |
A | 100.0 /100.0 |
4 /4 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 | |
2rqa[12] | B |
ZN
ZINC ION[1 atoms] |
A | 83.3 /31.2 |
6 /6 |
DHX58_HUMAN ATP-dependent RNA helicase DHX58 | |
2rqb[3] | B |
ZN
ZINC ION[1 atoms] |
A | 80.0 /31.6 |
5 /5 |
IFIH1_HUMAN Interferon-induced helicase C domain-containing pr.. | |
2ykg[3] | D |
ZN
ZINC ION[1 atoms] |
A | 100.0 /99.5 |
4 /4 |
DDX58_HUMAN PROBABLE ATP-DEPENDENT RNA HELICASE DDX58 | |
3lrn[4] | E |
ZN
ZINC ION[1 atoms] |
A | 100.0 /99.2 |
4 /4 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 | |
3ncu[2] | E |
ZN
ZINC ION[1 atoms] |
A | 100.0 /100.0 |
4 /4 |
DDX58_HUMAN RIG-I | |
3og8[9] | E |
ZN
ZINC ION[1 atoms] |
A | 100.0 /99.2 |
4 /4 |
RIGI_HUMAN Antiviral innate immune response receptor RIG-I | |
4ay2[7] | C |
ZN
ZINC ION[1 atoms] |
A | 100.0 /99.7 |
4 /4 |
DDX58_HUMAN PROBABLE ATP-DEPENDENT RNA HELICASE DDX58 | |
4bpb[23] | D |
ZN
ZINC ION[1 atoms] |
A | 100.0 /99.5 |
4 /4 |
DDX58_HUMAN PROBABLE ATP-DEPENDENT RNA HELICASE DDX58 | |
4gl2[10] | H |
ZN
ZINC ION[1 atoms] |
A | 80.0 /41.4 |
5 /5 |
IFIH1_HUMAN Interferon-induced helicase C domain-containing pr.. | |
5jaj[1] | D |
ZN
ZINC ION[1 atoms] |
A | 100.0 /35.4 |
4 /4 |
G0YYQ5_CHICK LGP2 | |
5jb2[3] | D |
ZN
ZINC ION[1 atoms] |
A | 100.0 /34.8 |
4 /4 |
G0YYQ5_CHICK LGP2 | |
6gjz[5] | D |
ZN
ZINC ION[1 atoms] |
A | 100.0 /38.8 |
4 /4 |
IFIH1_MOUSE Interferon-induced helicase C domain-containing pr.. | |
6gpg[1] | D |
ZN
ZINC ION[1 atoms] |
C | 100.0 /99.8 |
5 /5 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 | |
7bkp[4] | D |
ZN
ZINC ION[1 atoms] |
A | 100.0 /38.3 |
5 /5 |
IFIH1_MOUSE Interferon-induced helicase C domain-containing pr.. | |
7bkq[2] | D |
ZN
ZINC ION[1 atoms] |
A | 80.0 /38.6 |
5 /5 |
IFIH1_MOUSE Isoform 2 of Interferon-induced helicase C domain-.. | |
7jl0[4] | E |
ZN
ZINC ION[1 atoms] |
C | 100.0 /40.2 |
4 /4 |
IFIH1_HUMAN Interferon-induced helicase C domain-containing pr.. | |
7jl1[4] | H |
ZN
ZINC ION[1 atoms] |
A | 100.0 /100.0 |
4 /4 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I | |
7tnx[16] | D |
ZN
ZINC ION[1 atoms] |
A | 100.0 /100.0 |
4 /4 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I | |
8scz[1] | C |
ZN
ZINC ION[1 atoms] |
A | 100.0 /100.0 |
4 /4 |
RIGI_HUMAN Antiviral innate immune response receptor RIG-I | |
8t5s[1] | D |
ZN
ZINC ION[1 atoms] |
A | 100.0 /34.0 |
4 /4 |
G5EDI8_CAEEL Dicer-related helicase | |
3zd7[1] | E |
MG
MAGNESIUM ION[1 atoms] |
A | 100.0 /99.4 |
2 /2 |
DDX58_HUMAN PROBABLE ATP-DEPENDENT RNA HELICASE DDX58 | |
4a36[13] | H |
MG
MAGNESIUM ION[1 atoms] |
A | 100.0 /60.0 |
5 /5 |
D3TI84_ANAPL RETINOIC ACID INDUCIBLE PROTEIN I | |
4ay2[1] | E |
MG
MAGNESIUM ION[1 atoms] |
A | 100.0 /99.7 |
3 /3 |
DDX58_HUMAN PROBABLE ATP-DEPENDENT RNA HELICASE DDX58 | |
5e3h[5] | E |
MG
MAGNESIUM ION[1 atoms] |
A | 100.0 /100.0 |
2 /2 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 | |
5e3h[1] | F |
MG
MAGNESIUM ION[1 atoms] |
A | 100.0 /100.0 |
1 /1 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 | |
5e3h[2] | G |
MG
MAGNESIUM ION[1 atoms] |
A | 100.0 /100.0 |
2 /2 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 | |
5f98[6] | N |
MG
MAGNESIUM ION[1 atoms] |
A | 100.0 /100.0 |
2 /2 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 | |
5f9f[4] | N |
MG
MAGNESIUM ION[1 atoms] |
A | 100.0 /100.0 |
1 /1 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 | |
5f9h[2] | N |
MG
MAGNESIUM ION[1 atoms] |
A | 100.0 /100.0 |
4 /4 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 | |
5f9h[1] | O |
MG
MAGNESIUM ION[1 atoms] |
A | 100.0 /100.0 |
2 /2 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 | |
5f9h[1] | P |
MG
MAGNESIUM ION[1 atoms] |
A | 100.0 /100.0 |
1 /1 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 | |
5f9h[1] | U |
MG
MAGNESIUM ION[1 atoms] |
E | 100.0 /100.0 |
1 /1 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 | |
5f9h[1] | X |
MG
MAGNESIUM ION[1 atoms] |
G | 100.0 /100.0 |
2 /2 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 | |
5jaj[1] | G |
MG
MAGNESIUM ION[1 atoms] |
A | 100.0 /35.4 |
2 /2 |
G0YYQ5_CHICK LGP2 | |
5jb2[2] | G |
MG
MAGNESIUM ION[1 atoms] |
A | 100.0 /34.8 |
2 /2 |
G0YYQ5_CHICK LGP2 | |
5jb2[1] | H |
MG
MAGNESIUM ION[1 atoms] |
A | 0.0 /34.8 |
1 /1 |
G0YYQ5_CHICK LGP2 | |
5v9x[1] | H |
MG
MAGNESIUM ION[1 atoms] |
A | 100.0 /31.1 |
3 /3 |
A0A0D6HFY2_MYCSM ATP-dependent DNA helicase | |
6gkh[1] | F |
MG
MAGNESIUM ION[1 atoms] |
A | 100.0 /39.0 |
1 /1 |
IFIH1_MOUSE Interferon-induced helicase C domain-containing pr.. | |
6gpg[4] | E |
MG
MAGNESIUM ION[1 atoms] |
C | 100.0 /99.8 |
2 /2 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 | |
7bkp[1] | F |
MG
MAGNESIUM ION[1 atoms] |
A | 100.0 /38.3 |
1 /1 |
IFIH1_MOUSE Interferon-induced helicase C domain-containing pr.. | |
7jl0[1] | H |
MG
MAGNESIUM ION[1 atoms] |
C | 100.0 /40.2 |
1 /1 |
IFIH1_HUMAN Interferon-induced helicase C domain-containing pr.. | |
7mk1[2] | F |
MG
MAGNESIUM ION[1 atoms] |
A | 100.0 /100.0 |
1 /1 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I | |
7to2[3] | D |
MG
MAGNESIUM ION[1 atoms] |
A | 100.0 /100.0 |
2 /2 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I | |
8t5s[1] | E |
MG
MAGNESIUM ION[1 atoms] |
A | 100.0 /34.0 |
3 /3 |
G5EDI8_CAEEL Dicer-related helicase | |
6qv3[2] | F |
MN
MANGANESE (II) ION[1 atoms] |
A | 100.0 /31.9 |
2 /2 |
G0S0B9_CHATD Pre-mRNA splicing helicase-like protein | |
2qfd[10] | K |
HG
MERCURY (II) ION[1 atoms] |
A | 100.0 /100.0 |
4 /4 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 | |
2w4r[4] | E |
HG
MERCURY (II) ION[1 atoms] |
A | 100.0 /31.5 |
4 /4 |
DHX58_HUMAN PROBABLE ATP-DEPENDENT RNA HELICASE DHX58 | |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. | |||||||
HOMO | |||||||
925 | pdb_id | contact mol | homologue | ||||
a3 | description | a4 | identity[%]5 | Ncon6 | description | ||
4on9[2] | B | DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58[495 aa] | A | 100.0 /100.0 |
40 /40 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 | |
5f98[18] | C | DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58[648 aa] | A | 100.0 /100.0 |
20 /20 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 | |
5f98[6] | E | DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58[641 aa] | A | 100.0 /100.0 |
26 /26 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 | |
5f98[6] | G | DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58[647 aa] | A | 100.0 /100.0 |
1 /1 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 | |
5f98[6] | K | DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58[644 aa] | A | 100.0 /100.0 |
3 /3 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 | |
5f98[6] | G | DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58[647 aa] | C | 100.0 /100.0 |
11 /11 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 | |
5f98[6] | K | DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58[644 aa] | C | 100.0 /100.0 |
3 /3 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 | |
7jl3[2] | C | DDX58_HUMAN Antiviral innate immune response receptor RIG-I[65.. | A | 100.0 /100.0 |
7 /7 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I | |
7jl3[2] | E | DDX58_HUMAN Antiviral innate immune response receptor RIG-I[65.. | A | 100.0 /100.0 |
6 /6 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I | |
8g7t[4] | C | DDX58_HUMAN Antiviral innate immune response receptor RIG-I[61.. | A | 100.0 /100.0 |
10 /10 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I | |
8g7u[1] | A | DDX58_HUMAN Antiviral innate immune response receptor RIG-I[64.. | C | 100.0 /100.0 |
10 /10 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I | |
8g7v[1] | A | DDX58_HUMAN Antiviral innate immune response receptor RIG-I[64.. | C | 100.0 /100.0 |
9 /9 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I | |
4nqk[18] | B | DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58[188 aa] | A | 100.0 /100.0 |
21 /21 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 | |
4nqk[12] | D | DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58[188 aa] | A | 100.0 /100.0 |
12 /12 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 | |
4p4h[2] | E | DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58[188 aa] | A | 100.0 /99.5 |
3 /3 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 | |
4p4h[8] | H | DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58[188 aa] | A | 100.0 /99.5 |
2 /2 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 | |
6bzh[4] | C | DDX58_MOUSE Probable ATP-dependent RNA helicase DDX58[191 aa] | A | 82.4 /76.5 |
17 /17 |
DDX58_MOUSE Probable ATP-dependent RNA helicase DDX58 | |
6bzh[4] | D | DDX58_MOUSE Probable ATP-dependent RNA helicase DDX58[189 aa] | A | 72.7 /76.5 |
22 /22 |
DDX58_MOUSE Probable ATP-dependent RNA helicase DDX58 | |
7jl2[2] | E | IFIH1_HUMAN Interferon-induced helicase C domain-containing pr.. | C | 0.0 /40.2 |
9 /9 |
IFIH1_HUMAN Interferon-induced helicase C domain-containing pr.. | |
7jl2[2] | G | IFIH1_HUMAN Interferon-induced helicase C domain-containing pr.. | C | 0.0 /40.2 |
7 /9 |
IFIH1_HUMAN Interferon-induced helicase C domain-containing pr.. | |
7bkq[1] | A | IFIH1_MOUSE Isoform 2 of Interferon-induced helicase C domain-.. | A | 10.0 /38.6 |
10 /11 |
IFIH1_MOUSE Isoform 2 of Interferon-induced helicase C domain-.. | |
7bkq[1] | A | IFIH1_MOUSE Isoform 2 of Interferon-induced helicase C domain-.. | A | 14.3 /38.6 |
7 /13 |
IFIH1_MOUSE Isoform 2 of Interferon-induced helicase C domain-.. | |
5jc7[2] | B | D9N195_CHICK Melanoma differentiation associated protein-5[647 .. | A | 35.0 /38.0 |
20 /21 |
D9N195_CHICK Melanoma differentiation associated protein-5 | |
3eqt[2] | B | DHX58_HUMAN ATP-dependent RNA helicase DHX58[142 aa] | A | 0.0 /31.2 |
2 /2 |
DHX58_HUMAN ATP-dependent RNA helicase DHX58 | |
7w0a[2] | H | A1ZAW0_DROME Dicer-2, isoform A[1478 aa] | A | 46.4 /29.7 |
28 /55 |
A1ZAW0_DROME Dicer-2, isoform A | |
7w0d[1] | E | A1ZAW0_DROME Dicer-2, isoform A[660 aa] | D | 0.0 /29.7 |
1 /6 |
A1ZAW0_DROME Dicer-2, isoform A | |
7w0d[1] | D | A1ZAW0_DROME Dicer-2, isoform A[1544 aa] | E | 0.0 /29.7 |
2 /8 |
A1ZAW0_DROME Dicer-2, isoform A | |
8hf0[1] | A | A1ZAW0_DROME Dicer-2, isoform A[1561 aa] | D | 40.0 /29.7 |
5 /13 |
A1ZAW0_DROME Dicer-2, isoform A | |
8hf1[2] | D | A1ZAW0_DROME Dicer-2, isoform A[1561 aa] | A | 0.0 /29.7 |
7 /28 |
A1ZAW0_DROME Dicer-2, isoform A | |
8hf1[2] | A | A1ZAW0_DROME Dicer-2, isoform A[1561 aa] | D | 33.3 /29.7 |
6 /31 |
A1ZAW0_DROME Dicer-2, isoform A | |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. | |||||||
PRECIPITANT | |||||||
925 | pdb_id | contact mol | homologue | ||||
a3 | description | a4 | identity[%]5 | Ncon6 | description | ||
5e3h[1] | J |
BEF
BERYLLIUM TRIFLUORIDE ION[4 atoms] |
A | 100.0 /100.0 |
5 /5 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 | |
5f9f[1] | O |
ETF
TRIFLUOROETHANOL[6 atoms] |
A | 100.0 /100.0 |
9 /9 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 | |
5f9f[1] | Y |
ETF
TRIFLUOROETHANOL[6 atoms] |
E | 100.0 /100.0 |
5 /5 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 | |
5f9f[2] | CA |
ETF
TRIFLUOROETHANOL[6 atoms] |
G | 100.0 /100.0 |
5 /5 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 | |
5f9f[1] | NA |
ETF
TRIFLUOROETHANOL[6 atoms] |
K | 100.0 /100.0 |
6 /6 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 | |
5f9f[1] | P |
BU3
(R,R)-2,3-BUTANEDIOL[6 atoms] |
A | 100.0 /100.0 |
7 /7 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 | |
5f9f[1] | Q |
BU3
(R,R)-2,3-BUTANEDIOL[6 atoms] |
A | 100.0 /100.0 |
5 /5 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 | |
5f9f[2] | U |
BU3
(R,R)-2,3-BUTANEDIOL[6 atoms] |
A | 100.0 /100.0 |
5 /5 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 | |
5f9f[1] | T |
BU3
(R,R)-2,3-BUTANEDIOL[6 atoms] |
C | 100.0 /100.0 |
4 /4 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 | |
5f9f[1] | V |
BU3
(R,R)-2,3-BUTANEDIOL[6 atoms] |
C | 100.0 /100.0 |
4 /4 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 | |
5f9f[5] | W |
BU3
(R,R)-2,3-BUTANEDIOL[6 atoms] |
C | 100.0 /100.0 |
8 /8 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 | |
5f9f[2] | AA |
BU3
(R,R)-2,3-BUTANEDIOL[6 atoms] |
E | 100.0 /100.0 |
9 /9 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 | |
5f9f[1] | EA |
BU3
(R,R)-2,3-BUTANEDIOL[6 atoms] |
G | 100.0 /100.0 |
5 /5 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 | |
3tbk[1] | C |
EDO
1,2-ETHANEDIOL[4 atoms] |
A | 100.0 /78.8 |
7 /7 |
DDX58_MOUSE RIG-I Helicase Domain | |
5jaj[1] | H |
EDO
1,2-ETHANEDIOL[4 atoms] |
A | 60.0 /35.4 |
5 /5 |
G0YYQ5_CHICK LGP2 | |
5jaj[1] | I |
EDO
1,2-ETHANEDIOL[4 atoms] |
A | 50.0 /35.4 |
4 /5 |
G0YYQ5_CHICK LGP2 | |
5jaj[1] | J |
EDO
1,2-ETHANEDIOL[4 atoms] |
A | 50.0 /35.4 |
6 /6 |
G0YYQ5_CHICK LGP2 | |
6bzh[2] | F |
EDO
1,2-ETHANEDIOL[4 atoms] |
A | 100.0 /76.5 |
2 /2 |
DDX58_MOUSE Probable ATP-dependent RNA helicase DDX58 | |
6bzh[1] | I |
EDO
1,2-ETHANEDIOL[4 atoms] |
B | 100.0 /76.5 |
1 /3 |
DDX58_MOUSE Probable ATP-dependent RNA helicase DDX58 | |
6bzh[1] | J |
EDO
1,2-ETHANEDIOL[4 atoms] |
B | 100.0 /76.5 |
2 /2 |
DDX58_MOUSE Probable ATP-dependent RNA helicase DDX58 | |
6bzh[1] | J |
EDO
1,2-ETHANEDIOL[4 atoms] |
C | 75.0 /76.1 |
4 /4 |
DDX58_MOUSE Probable ATP-dependent RNA helicase DDX58 | |
4a36[2] | I |
AF3
ALUMINUM FLUORIDE[4 atoms] |
A | 100.0 /60.0 |
9 /9 |
D3TI84_ANAPL RETINOIC ACID INDUCIBLE PROTEIN I | |
5jaj[1] | F |
ALF
TETRAFLUOROALUMINATE ION[5 atoms] |
A | 100.0 /35.4 |
8 /8 |
G0YYQ5_CHICK LGP2 | |
5jb2[2] | F |
ALF
TETRAFLUOROALUMINATE ION[5 atoms] |
A | 100.0 /34.8 |
8 /8 |
G0YYQ5_CHICK LGP2 | |
6gkh[3] | E |
ALF
TETRAFLUOROALUMINATE ION[5 atoms] |
A | 100.0 /39.0 |
6 /6 |
IFIH1_MOUSE Interferon-induced helicase C domain-containing pr.. | |
7jl0[4] | G |
ALF
TETRAFLUOROALUMINATE ION[5 atoms] |
C | 100.0 /40.2 |
6 /6 |
IFIH1_HUMAN Interferon-induced helicase C domain-containing pr.. | |
7jl1[4] | F |
ALF
TETRAFLUOROALUMINATE ION[5 atoms] |
A | 100.0 /100.0 |
5 /5 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I | |
5jaj[1] | K |
MGF
TRIFLUOROMAGNESATE[4 atoms] |
A | 0.0 /35.4 |
1 /1 |
G0YYQ5_CHICK LGP2 | |
2w4r[4] | F |
SO4
SULFATE ION[5 atoms] |
A | 0.0 /31.5 |
3 /3 |
DHX58_HUMAN PROBABLE ATP-DEPENDENT RNA HELICASE DHX58 | |
2w4r[1] | K |
SO4
SULFATE ION[5 atoms] |
C | 25.0 /31.9 |
4 /4 |
DHX58_HUMAN PROBABLE ATP-DEPENDENT RNA HELICASE DHX58 | |
2ykg[3] | E |
SO4
SULFATE ION[5 atoms] |
A | 100.0 /99.5 |
7 /7 |
DDX58_HUMAN PROBABLE ATP-DEPENDENT RNA HELICASE DDX58 | |
3ts9[1] | B |
SO4
SULFATE ION[5 atoms] |
A | 100.0 /36.8 |
1 /1 |
IFIH1_MOUSE IFIH1_MOUSE Interferon-induced helicase C domain-containing pr.. | |
3ts9[4] | D |
SO4
SULFATE ION[5 atoms] |
A | 25.0 /36.8 |
4 /4 |
IFIH1_MOUSE IFIH1_MOUSE Interferon-induced helicase C domain-containing pr.. | |
4on9[2] | D |
SO4
SULFATE ION[5 atoms] |
A | 100.0 /100.0 |
4 /4 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 | |
4on9[2] | E |
SO4
SULFATE ION[5 atoms] |
A | 100.0 /100.0 |
1 /1 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 | |
5jbg[1] | G |
SO4
SULFATE ION[5 atoms] |
A | 50.0 /35.1 |
2 /3 |
G0YYQ5_CHICK LGP2 | |
5jbg[1] | H |
SO4
SULFATE ION[5 atoms] |
A | 33.3 /35.1 |
3 /3 |
G0YYQ5_CHICK LGP2 | |
5jbg[1] | I |
SO4
SULFATE ION[5 atoms] |
A | 0.0 /35.1 |
1 /1 |
G0YYQ5_CHICK LGP2 | |
5jbg[1] | J |
SO4
SULFATE ION[5 atoms] |
A | 25.0 /35.1 |
4 /4 |
G0YYQ5_CHICK LGP2 | |
6qws[1] | C |
SO4
SULFATE ION[5 atoms] |
A | 100.0 /31.9 |
5 /5 |
G0S0B9_CHATD Pre-mRNA splicing helicase-like protein | |
6qws[1] | E |
SO4
SULFATE ION[5 atoms] |
A | 100.0 /31.9 |
1 /3 |
G0S0B9_CHATD Pre-mRNA splicing helicase-like protein | |
5m59[4] | I |
ACT
ACETATE ION[4 atoms] |
B | 83.3 /31.9 |
6 /6 |
G0S0B9_CHATD Pre-mRNA splicing helicase-like protein | |
4a2v[1] | C |
GOL
GLYCEROL[6 atoms] |
A | 66.7 /55.3 |
6 /8 |
D3TI84_ANAPL RETINOIC ACID INDUCIBLE PROTEIN I | |
4a2v[1] | D |
GOL
GLYCEROL[6 atoms] |
A | 66.7 /55.3 |
3 /3 |
D3TI84_ANAPL RETINOIC ACID INDUCIBLE PROTEIN I | |
5e3h[1] | H |
GOL
GLYCEROL[6 atoms] |
A | 100.0 /100.0 |
5 /5 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 | |
5v9x[1] | E |
GOL
GLYCEROL[6 atoms] |
A | 0.0 /31.1 |
3 /9 |
A0A0D6HFY2_MYCSM ATP-dependent DNA helicase | |
5v9x[1] | G |
GOL
GLYCEROL[6 atoms] |
A | 50.0 /31.1 |
2 /4 |
A0A0D6HFY2_MYCSM ATP-dependent DNA helicase | |
5v9x[1] | I |
PEG
DI(HYDROXYETHYL)ETHER[7 atoms] |
A | 33.3 /31.1 |
3 /5 |
A0A0D6HFY2_MYCSM ATP-dependent DNA helicase | |
1wp9[6] | G |
PO4
PHOSPHATE ION[5 atoms] |
A | 85.7 /29.3 |
7 /7 |
Q8TZH8_PYRFU ATP-dependent RNA helicase, putative | |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. |